TM-233 is a dual-action small molecule that inhibits both JAK/STAT signaling and proteasome activity, leading to the induction of cell death in myeloma cells. It is a research tool used in vitro to study myeloma pathogenesis and therapeutic strategies, with applications in hematological cancer and targeted therapy research.
Molekulargewicht:
384.42
CAS Nummer:
[1103745-28-3]
Formel:
C25H20O4
Target-Kategorie:
NF-kappaB,Others,Bcl-2 Family,JAK,STAT
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten